IBERSOL | Integrated Management Report | 2025

INTEGRATED MANAGEMENT REPORT 2025 6.7.Investments in associates and joint ventures Accounting policies Investments in joint ventures and associated companies are recorded in accordance with the equity method of accounting and are included in the consolidated statement of financial position in the caption “Investments in associated and joint ventures”. In accordance with the equity method, financial investments are recorded at their acquisition cost and the carrying amount is subsequently increased or decreased to recognize the Group’s share of the profits or losses of the associate or joint venture, and for dividends received. The differences between the acquisition price and the fair value of the identifiable assets and liabilities of the joint ventures and associates on the acquisition date, if positive, are recognized as Goodwill and maintained in the value of the financial investment in joint ventures and associates. Investments in associates are subject to impairment tests whenever there are indications of impairment. An impairment loss is recognized in the income statement for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell and its value in use. To perform impairment tests, each investment is analyzed separately. Impairment losses on financial investments in associates are reversible. In the periods ended 31 December 2025 and 2024, investments in associates and joint ventures were broken down as follows: dec. 2025 dec. 2024 UQ Consult - Serviços de Apoio à Gestão, S.A. 2 679 030 2 783 601 Ziaicos - Serviços e gestão, Lda 197 423 194 129 Gut & Schnell, SL 166 047 137 157 Sapidium Ferrolterra, SL 1 042 786 1 025 619 Original Chicken Compostela, SL 850 422 857 866 Frisch Vigo, SL 15 901 2 500 Frisch Pontevedra, SL 432 668 445 988 Lecker Ourense, SL 56 935 35 000 5 441 211 5 481 859 Accumulated impairment losses - - Total 5 441 211 5 481 859 435